FOLFIRI Combined with Bevacizumab as First-Line Treatment for Metastatic Colorectal Cancer Patients with Hyperbilirubinemia after UGT1A1 Genotyping
2014 ◽
Vol 23
(5)
◽
pp. 478-481
◽
2007 ◽
Vol 96
(3)
◽
pp. 439-444
◽
2010 ◽
Vol 26
(2)
◽
pp. 143-151
◽
2018 ◽
Vol 125
◽
pp. 69-77
◽